Easton Pharmaceuticals Secures Financing Commitment Towards

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Easton Pharmaceuticals Secures Financing Commitment Towards Closing of Its Option on Canadian Medical Marijuana Facility and Business

TORONTO, ON--(Marketwired - Oct 13, 2014) - Easton Pharmaceuticals Inc. ( OTC : EAPH ) announces it has sourced out and secured financing commitment for the full amount owed on its option to purchase its entire ownership interest on its Canadian medical marijuana Initiative.

The financing commitment including cash the company currently has in hand is over and above what is required for Easton to close on its exclusive option agreement to purchase up to 49% of its Canadian medical marijuana business and initiative that has received a letter to build from Health Canada under the country's new MMPR system. The financing commitment is from a private Canadian accredited investor. The funding is to be forwarded to the Company upon receiving a Health Canada MMPR license as per the option agreement signed in June of this year. Complete terms to be disclosed at that time. The company is now focusing on reviewing agreements executed in June of this year when it purchased its option as well as receiving a detailed progress report on the status of the licensing process. Unfortunately, Easton is not able at this time to disclose any additional details on the MMJ property including any pictures of the facilities, which was previously stated in error.

Carla Pepe, CEO of Easton Pharmaceuticals commented, "We are pleased to have received the financing commitment which allows us to purchase and close on our entire option once the license has been received. The financing allows us to focus on other initiatives while we await a final license along with its partners. The commitment is solely for the Canadian medical marijuana initiative and is not to be utilized on any other business segments. Easton will continue to pursue other additional financing to further its other initiatives including its OTC products, its 2 drugs where it owns 50% and 10% of 2 drugs respectively, as well as having cash on hand to advance on other possible initiatives within the State of California it hopes to soon finalize and announce. This also includes its current partnership with AMFIL Technologies who have shipped an mPact-GROzone Antimicrobial System to a large grower in the State of Colorado and others."

Although the industry wide licensing process with health Canada is progressing slower than expected due to the large amount of applications and the new security measures that were implemented for all applicants, management believes as do others in the industry, that only companies who currently have a letter to build, will ultimately receive licenses with no more than 50 licenses in total being approved by health Canada. Health Canada projects the Canadian medical marijuana industry will grow in the Billions in the next few years which is approved nationally. The current liberal minority government has made full legalization of Cannabis as its platform.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors and others industries such as medical marijuana. The Company owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues geared towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company has ventured into the potentially lucrative medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system and the exclusive option to purchase up to 50% in a medical marijuana grow-op business / facility which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of Cannabidiol extracts.

For More Information Visit: http://www.eastonpharmaceuticalsinc.com

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "hope," "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.

Contact: Carla Pepe Easton Pharmaceuticals Inc. Tel: +1(416) 619-0291 Tel: +1(347) 284-0192 Email: info@eastonpharmaceuticalsinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UTI Faces Fresh Scrutiny After Its Earnings Guidance Miss

Updated Category News Views 113

A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...

Continue Reading
TNBC Advocate Campaign Targets Gaps in Patient Clarity

Updated Category News Views 70

Triple-negative is a heavy phrase to hand somebody without a map. Tigerlily Foundation and the Breast Cancer Resource Center are trying to close that gap with a national education campaign scheduled to launch publicly on January 11, 2027. The plan is straightforward on paper: train and mobilize 100 patient advocates across the country to explain triple-negative breast...

Continue Reading
Greenberg Traurig Builds Real Estate Bench Further

Updated Category News Views 66

Two real estate lawyers rarely move a market, but they can tell you where the legal work is getting sticky. Greenberg Traurig’s November 19 addition of Steven A. Fein and Kelsey Thayer is not some grand macroeconomic pronouncement, and nobody should pretend otherwise. It is, however, a pretty sensible read on the messy corners of commercial property finance: joint...

Continue Reading
J. Harmon Tests a Smarter Cannabis Accessory Niche

Updated Category News Views 118

Aisle Space Is the Real Prize Most cannabis accessory launches arrive dressed up like a gimmick and disappear before anyone has reordered them. J. Harmon has a more sensible target: give women products that look deliberate, work in everyday routines and do not demand designer-level money. The brand is set to debut at MJBizCon 2026 in Las Vegas, with LUVBUDS handling...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 144

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
Allstate's October Cat Loss Lands at $232 Million Net

Updated Category News Views 75

October’s weather bill arrived without much poetry: $232 million in estimated catastrophe losses at Allstate. Reported on November 19, that figure falls to $184 million after tax, and it deserves a clear-eyed read rather than the usual insurance-stock theatrics. A single monthly catastrophe tally is not a verdict on the company, but it is absolutely part of the...

Continue Reading
Birla Carbon's Rayong Bet Tightens Asian Supply Lines

Updated Category News Views 105

Rayong just became a much louder pin on Asia's industrial map. Birla Carbon has inaugurated a 120 kMT carbon black plant in Thailand, and the significance is bigger than a ribbon-cutting photo. This is a capacity-and-location move aimed squarely at the uncomfortable part of industrial supply chains: customers need material when they need it, not after it has spent weeks...

Continue Reading
Specialized Metal Makers Become the New M&A Prize Again

Updated Category News Views 36

A forgotten heat-treatment line can suddenly be worth more than a shiny new mill when buyers realize nobody can duplicate its certifications, workforce, and customer approvals overnight. That is the basic truth sitting underneath BGL's Nov. 19, 2026 assessment of the U.S. metals market. The easy headline is consolidation. The useful takeaway is much narrower: specialized...

Continue Reading
Makers Nutrition Backs Families Through Friends of Karen

Updated Category News Views 79

A thousand dollars in gift cards can look modest beside the noise of holiday marketing, but it lands differently when a family is carrying the weight of a child’s life-threatening illness. Makers Nutrition, a Hauppauge, New York-based private-label and custom supplement manufacturer, has donated $1,000 in gift cards to Friends of Karen for the nonprofit’s annual...

Continue Reading
Robert Half's Parent Support Earns Fortune Recognition

Updated Category News Views 106

A workplace award rarely moves a staffing stock by itself, and it shouldn’t. Still, Fortune naming Robert Half among its Best Workplaces for Parents for 2026 is more than decorative corporate wallpaper. In the talent business, the company’s own ability to recruit, retain and support people is part of the product. Clients hire Robert Half because they need skilled...

Continue Reading

Top 5 Most Recently Viewed Articles

Spectral Medical Secures $3 Million Funding for Growth

Updated Category News Views 100

Spectral Medical Secures a $3 Million Funding Boost In a significant development, Spectral Medical Inc. has successfully secured a $3 million advance through a collaboration with Vantive US Healthcare LLC. This funding serves as a vital resource for Spectral, a company dedicated to enhancing therapeutic treatments for sepsis and septic shock. Strengthening Financial...

Continue Reading
Exploring the Thriving Hyperscale Data Center Industry

Updated Category News Views 192

Hyperscale Data Centers: A Market on the Move The global hyperscale data center market is set to expand quickly, with projections pointing to USD 177.58 billion in the coming years, up from USD 111.57 billion in the previous year. From 2024 to 2032, forecasts call for a compound annual growth rate (CAGR) of 5.3%. Behind that curve: rising demand for cloud services, rapid...

Continue Reading
Stock Market Sees Positive Gains Amid Mixed Economic Sentiment

Updated Category News Views 122

Stock Market Overview and Performance The Fear and Greed index indicates stability in market perceptions, remaining in the "Neutral" zone despite fluctuations. On the latest trading day, U.S. stocks demonstrated an upward trend, specifically highlighting a surge of over 300 points in the Dow Jones index during this session. Key Stock Performances Particularly notable were...

Continue Reading
Peyto Exploration Declares Monthly Dividend for November 2025

Updated Category News Views 161

Peyto Exploration & Development Corp. Announces Dividend Details CALGARY, Alberta — Peyto Exploration & Development Corp. (TSX: PEY) proudly announces that its monthly dividend of $0.11 per common share will be disbursed on November 14, 2025. This payment is dedicated to shareholders who are on record as of October 31, 2025. Understanding the Dividend Payment The...

Continue Reading
Investors Alert: Rentokil Initial Class Action Lawsuit Details

Updated Category News Views 333

Rentokil Initial Class Action Lawsuit Overview In a recent development, investors holding American Depositary Shares (ADSs) in Rentokil Initial plc are being notified of an impending deadline in a securities class action lawsuit. Those who have suffered losses exceeding $100,000 can apply to be lead plaintiffs. The deadline for filing these applications is January 27,...

Continue Reading